These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation. Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539 [TBL] [Abstract][Full Text] [Related]
47. Parallel striatal and hippocampal systems for landmarks and boundaries in spatial memory. Doeller CF; King JA; Burgess N Proc Natl Acad Sci U S A; 2008 Apr; 105(15):5915-20. PubMed ID: 18408152 [TBL] [Abstract][Full Text] [Related]
48. Dopaminergic modulation of hippocampus-dependent learning: blockade of hippocampal D1-class receptors during learning impairs 1-trial place memory at a 30-min retention delay. Pezze M; Bast T Neuropharmacology; 2012 Sep; 63(4):710-8. PubMed ID: 22659087 [TBL] [Abstract][Full Text] [Related]
50. Greater striatal responses to medication in Parkinson׳s disease are associated with better task-switching but worse reward performance. Aarts E; Nusselein AA; Smittenaar P; Helmich RC; Bloem BR; Cools R Neuropsychologia; 2014 Sep; 62():390-7. PubMed ID: 24912070 [TBL] [Abstract][Full Text] [Related]
51. Dissociable spatial memory systems revealed by typical and atypical human development. Julian JB; Kamps FS; Epstein RA; Dilks DD Dev Sci; 2019 Mar; 22(2):e12737. PubMed ID: 30176106 [TBL] [Abstract][Full Text] [Related]
52. The well-worn route revisited: Striatal and hippocampal system contributions to familiar route navigation. Buckley M; McGregor A; Ihssen N; Austen J; Thurlbeck S; Smith SP; Heinecke A; Lew AR Hippocampus; 2024 Jul; 34(7):310-326. PubMed ID: 38721743 [TBL] [Abstract][Full Text] [Related]
53. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory. Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401 [TBL] [Abstract][Full Text] [Related]
54. The role of dopamine in action control: Insights from medication effects in Parkinson's disease. Ruitenberg MFL; van Wouwe NC; Wylie SA; Abrahamse EL Neurosci Biobehav Rev; 2021 Aug; 127():158-170. PubMed ID: 33905788 [TBL] [Abstract][Full Text] [Related]
55. Selective neural coding of object, feature, and geometry spatial cues in humans. Ramanoël S; Durteste M; Bizeul A; Ozier-Lafontaine A; Bécu M; Sahel JA; Habas C; Arleo A Hum Brain Mapp; 2022 Dec; 43(17):5281-5295. PubMed ID: 35776524 [TBL] [Abstract][Full Text] [Related]
56. Hippocampus-Dependent Goal Localization by Head-Fixed Mice in Virtual Reality. Sato M; Kawano M; Mizuta K; Islam T; Lee MG; Hayashi Y eNeuro; 2017; 4(3):. PubMed ID: 28484738 [TBL] [Abstract][Full Text] [Related]
57. The effects of dopaminergic medication on dynamic decision making in Parkinson's disease. Osman M; Ryterska A; Karimi K; Tu L; Obeso I; Speekenbrink M; Jahanshahi M Neuropsychologia; 2014 Jan; 53():157-64. PubMed ID: 24269857 [TBL] [Abstract][Full Text] [Related]
58. Striatal serotonin depletion facilitates rat egocentric learning via dopamine modulation. Anguiano-Rodríguez PB; Gaytán-Tocavén L; Olvera-Cortés ME Eur J Pharmacol; 2007 Feb; 556(1-3):91-8. PubMed ID: 17126827 [TBL] [Abstract][Full Text] [Related]
59. The Michelin red guide of the brain: role of dopamine in goal-oriented navigation. Retailleau A; Boraud T Front Syst Neurosci; 2014; 8():32. PubMed ID: 24672436 [TBL] [Abstract][Full Text] [Related]
60. Testing the dopamine overdose hypothesis in action control: A study in people with Parkinson's disease. Ruitenberg MFL; Abrahamse EL; Santens P; Notebaert W J Neuropsychol; 2023 Jun; 17(2):264-278. PubMed ID: 36303524 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]